A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus (T2DM); Obesity Interventions: Drug: Placebo; Drug: Rosuvastatin; Drug: Midazolam; Drug: Omeprazole; Drug: PF-06954522 Sponsors: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Crestor | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Learning | Obesity | Omeprazole | Pfizer | Prilosec | Research | Rosuvastatin | Study | Universities & Medical Training